Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corsten

Showing results (181-190 of 239) with videos related to

Pageof 24
Sort By:
Chemmedchem|March 31, 2007
From dioxin to drug lead--the development of 2,3,7,8-tetrachlorophenothiazineKristian W Fried, Christopher M Schneider, Karl-Werner Schramm, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|August 12, 2025
Getting valuable and valid insight in life after ICU: Evaluating the representativeness of a large cohort of ICU survivorsJulian van Gemert, Marieke Zegers, Eddy Adang, et al.
Critical Care Medicine|February 24, 2023
Development and External Validation of a Prediction Model for Quality of Life of ICU Survivors: A Subanalysis of the MONITOR-IC Prospective Cohort StudyLucy L Porter, Koen S Simons, Jordache Ramjith, et al.
Annals of Hematology|August 30, 2024
Cold case: COVID-19-triggered type 1 cryoglobulinemiaL A J Luuk van Gils, M F Maarten Corsten, C A Carin Koelman, et al.
Annals of Neurology|January 5, 2026
Brain Atrophy Associated With Risk Variant rs10191329 Extends Beyond Multiple SclerosisCato E A Corsten, Ana M Marques, Elisabeth J Vinke, et al.
Plos One|August 23, 2023
Comparison of socio-economic determinants of COVID-19 testing and positivity in Canada: A multi-provincial analysisLilia Antonova, Chandy Somayaji, Jillian Cameron, et al.
OTO Open|July 12, 2021
Treatment Choices in Managing Bethesda III and IV Thyroid Nodules: A Canadian Multi-institutional StudyVictoria Kuta, David Forner, Jason Azzi, et al.
Journal of Hematopathology|October 9, 2025
Analysis of myeloid neoplasms with isolated trisomy 19 reveals a novel MDS subgroup characterized by the presence of ring sideroblasts, fibrosis and SRSF2 and/or ASXL1 mutationsKonnie M Hebeda, Ludmila Boudová, Maarten F Corsten, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2013
Is lower socioeconomic status associated with more advanced thyroid cancer stage at presentation? A study in two Canadian centersStephanie Siu, James Ted McDonald, Murali Rajaraman, et al.
Cells|May 28, 2022
Distinct Effector Programs of Brain-Homing CD8<sup>+</sup> T Cells in Multiple SclerosisSteven C Koetzier, Jamie van Langelaar, Marie-José Melief, et al.
Pageof 24

Showing results (181-190 of 239) with videos related to

Sort By:
Pageof 24
Chemmedchem|March 31, 2007
From dioxin to drug lead--the development of 2,3,7,8-tetrachlorophenothiazineKristian W Fried, Christopher M Schneider, Karl-Werner Schramm, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|August 12, 2025
Getting valuable and valid insight in life after ICU: Evaluating the representativeness of a large cohort of ICU survivorsJulian van Gemert, Marieke Zegers, Eddy Adang, et al.
Critical Care Medicine|February 24, 2023
Development and External Validation of a Prediction Model for Quality of Life of ICU Survivors: A Subanalysis of the MONITOR-IC Prospective Cohort StudyLucy L Porter, Koen S Simons, Jordache Ramjith, et al.
Annals of Hematology|August 30, 2024
Cold case: COVID-19-triggered type 1 cryoglobulinemiaL A J Luuk van Gils, M F Maarten Corsten, C A Carin Koelman, et al.
Annals of Neurology|January 5, 2026
Brain Atrophy Associated With Risk Variant rs10191329 Extends Beyond Multiple SclerosisCato E A Corsten, Ana M Marques, Elisabeth J Vinke, et al.
Plos One|August 23, 2023
Comparison of socio-economic determinants of COVID-19 testing and positivity in Canada: A multi-provincial analysisLilia Antonova, Chandy Somayaji, Jillian Cameron, et al.
OTO Open|July 12, 2021
Treatment Choices in Managing Bethesda III and IV Thyroid Nodules: A Canadian Multi-institutional StudyVictoria Kuta, David Forner, Jason Azzi, et al.
Journal of Hematopathology|October 9, 2025
Analysis of myeloid neoplasms with isolated trisomy 19 reveals a novel MDS subgroup characterized by the presence of ring sideroblasts, fibrosis and SRSF2 and/or ASXL1 mutationsKonnie M Hebeda, Ludmila Boudová, Maarten F Corsten, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2013
Is lower socioeconomic status associated with more advanced thyroid cancer stage at presentation? A study in two Canadian centersStephanie Siu, James Ted McDonald, Murali Rajaraman, et al.
Cells|May 28, 2022
Distinct Effector Programs of Brain-Homing CD8<sup>+</sup> T Cells in Multiple SclerosisSteven C Koetzier, Jamie van Langelaar, Marie-José Melief, et al.
Pageof 24